Clinical Approach to Delayed Puberty

Pediatric Endocrinology Framework

1
Symptom Overview
Overview
2
Pathophysiology
Mechanism
3
History Taking
History
4
Physical Examination
Examination
5
Differential Diagnosis
Differential
6
Investigations
Workup
7
Clinical Decision-Making
Algorithm
8
Pearls and Pitfalls
Summary

1. Symptom Overview

Understanding the clinical significance and classification of delayed puberty

Delayed puberty is one of the most common reasons for referral to pediatric endocrinology, affecting approximately 2-3% of adolescents. While the majority of cases represent constitutional delay of growth and puberty—a normal variant that runs in families—delayed puberty can also be the presenting sign of serious underlying conditions including chronic disease, genetic syndromes, or hypothalamic-pituitary disorders. Early recognition and appropriate evaluation are essential to identify those requiring intervention and to address the significant psychosocial impact on affected adolescents.

Definition

Delayed puberty is defined as the absence of physical signs of pubertal development at an age that is 2 to 2.5 standard deviations beyond the population mean for the onset of puberty.

In boys: No testicular enlargement (volume <4 mL or length <2.5 cm) by age 14 years
In girls: No breast development (Tanner stage 2) by age 13 years, OR no menarche by age 15-16 years (primary amenorrhea)

Delayed puberty also includes arrested puberty—failure to progress through puberty within the expected timeframe (typically >4-5 years from onset to completion).

Key Epidemiology

Affects approximately 2-3% of adolescents
More common in boys presenting for evaluation (male-to-female ratio approximately 2:1)
Constitutional delay of growth and puberty (CDGP) accounts for 50-65% of cases in boys and 25-30% in girls
Permanent hypogonadism is found in approximately 10-20% of evaluated cases
Functional hypogonadotropic hypogonadism (due to chronic illness, stress, or undernutrition) is more common in girls

Classification by Etiology

Delayed puberty is classified based on the underlying pathophysiology, which guides both evaluation and management. The distinction between central (hypothalamic-pituitary) and gonadal causes is fundamental.

Category	Gonadotropins (LH/FSH)	Sex Steroids	Key Causes	Approximate Frequency
Constitutional Delay of Growth and Puberty	Low (prepubertal) initially, then normal	Low initially, then normal	Normal variant; family history of “late bloomers”	50-65% (boys), 25-30% (girls)
Hypogonadotropic Hypogonadism (Central)	Low or inappropriately normal	Low	Kallmann syndrome, pituitary tumors, chronic disease, functional (undernutrition, stress)	10-20%
Hypergonadotropic Hypogonadism (Gonadal)	High (elevated)	Low	Turner syndrome, Klinefelter syndrome, gonadal dysgenesis, chemotherapy/radiation	10-25%

Normal Pubertal Development: Key Milestones

Understanding normal pubertal timing is essential for recognizing delay. Puberty follows a predictable sequence, though the age of onset varies.

Boys

First sign: Testicular enlargement (>4 mL volume or >2.5 cm length)

Normal onset age: 9-14 years (mean ~11.5 years)

Sequence: Testicular enlargement → pubic hair → penile growth → peak height velocity → axillary hair, voice change, facial hair

Duration: 3-4 years from onset to completion

Peak height velocity: Tanner stage 3-4 (average 10-12 cm/year)

Girls

First sign: Breast budding (thelarche)

Normal onset age: 8-13 years (mean ~10.5 years)

Sequence: Breast development → pubic hair → peak height velocity → menarche

Duration: 2-3 years from thelarche to menarche

Peak height velocity: Tanner stage 2-3 (average 8-9 cm/year)

Menarche: Typically 2-2.5 years after thelarche (mean age ~12.5 years)

Tanner Staging Reference

Stage	Boys (Genitalia)	Girls (Breast)	Pubic Hair (Both)
1	Prepubertal; testes <4 mL	Prepubertal; no glandular tissue	No pubic hair
2	Testes 4-8 mL; scrotum reddening	Breast bud; areolar enlargement	Sparse, slightly pigmented hair at base of penis/labia
3	Testes 8-12 mL; penile lengthening	Breast and areola enlarge; no separate contour	Darker, coarser, curly hair spreading over pubis
4	Testes 12-15 mL; penile growth in width	Areola forms secondary mound	Adult-type hair, not yet spreading to thighs
5	Adult testes (>15-25 mL); adult genitalia	Adult breast; areola recedes to breast contour	Adult distribution, extends to medial thighs

Clinical Subtypes of Delayed Puberty

Subtype	Definition	Typical Presentation	Prognosis
Complete Absence of Puberty	No pubertal signs beyond defined age thresholds	Tanner stage 1 at age 14 (boys) or 13 (girls)	Depends on etiology; may be transient (CDGP) or permanent
Arrested or Stalled Puberty	Puberty initiated but fails to progress for >2 years	Partial pubertal development that stops	Higher suspicion for pathology; requires thorough evaluation
Primary Amenorrhea	No menarche by age 15-16 with breast development, OR by age 13-14 without breast development	Girls with or without other pubertal signs	Requires anatomical evaluation in addition to hormonal workup

Psychosocial Impact

The psychosocial effects of delayed puberty should not be underestimated and are an important consideration in management decisions:

Short stature relative to peers — often the primary concern for boys
Body image concerns — feeling physically immature compared to peers
Social isolation and bullying — being excluded from peer activities or teased
Low self-esteem and depression — can persist into adulthood if unaddressed
Academic and athletic performance — may be affected by psychological distress
Anxiety about fertility and sexual function — especially in older adolescents

Key Concept: Constitutional delay of growth and puberty (CDGP) is the most common cause of delayed puberty, especially in boys, but it is a diagnosis of exclusion. The clinical challenge lies in distinguishing CDGP (which requires only reassurance and monitoring) from permanent hypogonadotropic hypogonadism (which requires lifelong hormone replacement). Initial biochemical testing often cannot differentiate these conditions, making clinical judgment and follow-up essential.

2. Pathophysiology and Mechanisms

Understanding the hypothalamic-pituitary-gonadal axis and mechanisms of delayed puberty

Puberty is initiated and regulated by the reactivation of the hypothalamic-pituitary-gonadal (HPG) axis, which is active during fetal life and early infancy (“mini-puberty”) but then becomes quiescent during childhood. Understanding this axis is fundamental to diagnosing and managing delayed puberty, as disruption at any level—hypothalamus, pituitary, or gonads—can result in pubertal delay.

The Hypothalamic-Pituitary-Gonadal Axis

Level	Structure	Hormone Produced	Target	Function
Hypothalamus	GnRH neurons (arcuate nucleus)	Gonadotropin-releasing hormone (GnRH)	Anterior pituitary gonadotrophs	Pulsatile secretion stimulates LH and FSH release
Pituitary	Anterior pituitary gonadotrophs	Luteinizing hormone (LH) and Follicle-stimulating hormone (FSH)	Gonads (testes/ovaries)	LH: stimulates sex steroid production; FSH: stimulates gametogenesis
Gonads	Testes (Leydig cells, Sertoli cells) / Ovaries (theca, granulosa cells)	Testosterone (boys), Estradiol and Progesterone (girls), Inhibin B	Multiple tissues; hypothalamus and pituitary (feedback)	Secondary sexual characteristics, gametogenesis, growth, negative feedback

Regulation of Pubertal Onset

The timing of pubertal onset is controlled by a complex interplay of genetic, nutritional, and environmental factors that regulate the “GnRH pulse generator.”

Stimulatory Factors

Kisspeptin: The key upstream activator of GnRH neurons; mutations in KISS1 or KISS1R cause hypogonadotropic hypogonadism

Neurokinin B: Works with kisspeptin to stimulate GnRH release

Leptin: Signals adequate energy stores; required for pubertal initiation

Genetic factors: >50% of pubertal timing variance is heritable

Inhibitory Factors

GABA: Inhibits GnRH neurons during childhood

Opioid peptides: Suppress GnRH secretion

MKRN3: Maternally imprinted gene that inhibits pubertal onset; loss-of-function causes precocious puberty

Melatonin: May play a role in seasonal/circadian regulation

Metabolic Signals

Nutritional status: Chronic undernutrition delays puberty

Body composition: Adequate fat mass is required (leptin signaling)

Chronic illness: Any chronic disease can suppress the HPG axis

Excessive exercise: Can suppress GnRH pulsatility

Mechanisms of Delayed Puberty by Category

Category	Pathophysiological Mechanism	Key Examples	Clinical Implications
Constitutional Delay of Growth and Puberty	Physiological delay in reactivation of the GnRH pulse generator; HPG axis is intact but matures later than average	Familial pattern of late puberty; often accompanied by delayed bone age	Self-limited; puberty will eventually occur spontaneously; final adult height typically normal
Functional Hypogonadotropic Hypogonadism	Reversible suppression of GnRH pulsatility due to inadequate energy availability, chronic disease, or stress	Anorexia nervosa, excessive exercise (female athlete triad), chronic inflammatory disease, celiac disease	Reversible with treatment of underlying condition and restoration of energy balance
Permanent Hypogonadotropic Hypogonadism	Congenital or acquired defect in GnRH secretion or action, or pituitary gonadotroph dysfunction	Kallmann syndrome (GnRH neuron migration defect + anosmia), isolated GnRH deficiency, pituitary tumors, cranial irradiation	Requires lifelong hormone replacement therapy; may require fertility treatment
Hypergonadotropic Hypogonadism	Primary gonadal failure leads to loss of negative feedback, resulting in elevated LH and FSH	Turner syndrome (45,X), Klinefelter syndrome (47,XXY), gonadal dysgenesis, chemotherapy/radiation damage	Permanent; requires hormone replacement; fertility typically impaired but not always impossible

Specific Pathophysiological Mechanisms

Kallmann Syndrome

Kallmann syndrome results from a failure of GnRH neurons to migrate from the olfactory placode to the hypothalamus during embryonic development. Because GnRH neurons and olfactory neurons share a common migratory pathway, patients have both hypogonadotropic hypogonadism (absent or incomplete puberty) and anosmia or hyposmia (absent or reduced sense of smell).

Inheritance: X-linked (KAL1/ANOS1), autosomal dominant, or autosomal recessive; many cases are sporadic
Associated features: Renal agenesis, synkinesia (mirror movements), cleft lip/palate, dental agenesis, hearing loss
MRI findings: Absent or hypoplastic olfactory bulbs and sulci

Turner Syndrome (45,X and Variants)

In Turner syndrome, accelerated oocyte atresia leads to “streak gonads” with fibrous tissue replacing functional ovarian tissue. The resulting lack of estrogen production causes elevated gonadotropins (hypergonadotropic hypogonadism).

Gonadal function: ~30% have some spontaneous pubertal development; ~2-5% may have spontaneous menses
Other features: Short stature, webbed neck, shield chest, cardiac defects (coarctation, bicuspid aortic valve), renal anomalies
Management: Growth hormone for short stature; estrogen replacement for pubertal induction and bone health

Klinefelter Syndrome (47,XXY)

The extra X chromosome leads to progressive testicular fibrosis and failure, typically becoming evident during puberty. Early pubertal development may be normal, but puberty often stalls, and testosterone levels decline.

Presentation: May present with delayed puberty, gynecomastia, small firm testes, tall stature with eunuchoid proportions
Gonadotropins: Typically elevated by mid-puberty (hypergonadotropic)
Fertility: Azoospermia is common, but sperm retrieval techniques may be possible in some cases

Functional Hypothalamic Amenorrhea

In girls, energy deficit (from restrictive eating, excessive exercise, or both) suppresses kisspeptin and GnRH pulsatility, leading to low LH, FSH, and estradiol. This is the mechanism underlying the Female Athlete Triad (disordered eating, amenorrhea, low bone mineral density).

Pathophysiology: Low leptin from inadequate fat mass fails to stimulate kisspeptin neurons
Reversibility: Puberty progresses once energy balance is restored
Consequences: Impaired bone mineral density accrual if prolonged

Why Certain Conditions Cause Delayed Puberty

Condition	Mechanism of Pubertal Delay	Expected Gonadotropin Pattern
Celiac Disease	Chronic inflammation and malabsorption lead to nutritional deficiency, suppressing the HPG axis	Low LH, FSH (hypogonadotropic)
Inflammatory Bowel Disease	Chronic inflammation, malnutrition, and corticosteroid use suppress GnRH secretion	Low LH, FSH (hypogonadotropic)
Cystic Fibrosis	Chronic illness, nutritional deficits, and pancreatic insufficiency impair growth and puberty	Low LH, FSH (hypogonadotropic)
Craniopharyngioma	Tumor compresses or destroys GnRH neurons or pituitary gonadotrophs	Low LH, FSH (hypogonadotropic)
Cranial Irradiation	Radiation damages hypothalamic GnRH neurons; higher doses affect pituitary directly	Low LH, FSH (hypogonadotropic); may evolve over time
Gonadal Irradiation or Chemotherapy	Direct gonadal toxicity destroys germ cells and/or steroidogenic cells	High LH, FSH (hypergonadotropic)
Prader-Willi Syndrome	Hypothalamic dysfunction leads to GnRH deficiency; hyperphagia and obesity also contribute	Low LH, FSH (hypogonadotropic)
Hypothyroidism	Severe hypothyroidism can delay puberty; thyrotropin-releasing hormone (TRH) cross-stimulates prolactin, which inhibits GnRH	Usually low or normal LH, FSH; elevated prolactin may be present
Hyperprolactinemia	Elevated prolactin (from prolactinoma or medications) inhibits GnRH pulsatility	Low LH, FSH (hypogonadotropic)

Often Overlooked Mechanism: The Mini-Puberty Window

The HPG axis is transiently active during the first 6 months of life (“mini-puberty”). During this period, LH and FSH levels are elevated and can be measured. In boys, testosterone rises to near-pubertal levels; in girls, estradiol may fluctuate. This window provides a unique opportunity to diagnose congenital hypogonadotropic hypogonadism in infancy—before the axis becomes quiescent and biochemical testing becomes unreliable. If a male infant has micropenis or cryptorchidism, measuring gonadotropins and testosterone during the first 3-6 months can establish or exclude a diagnosis of hypogonadotropic hypogonadism years before delayed puberty would become apparent.

The Diagnostic Challenge: CDGP versus Isolated Hypogonadotropic Hypogonadism

One of the most difficult diagnostic dilemmas in pediatric endocrinology is distinguishing constitutional delay of growth and puberty from permanent isolated hypogonadotropic hypogonadism (IHH). Both conditions present with:

Delayed pubertal development
Prepubertal or low gonadotropin levels (LH, FSH)
Low sex steroid levels (testosterone or estradiol)
Delayed bone age

No single test reliably differentiates these conditions. The key distinguishing features include:

Feature	Constitutional Delay (CDGP)	Isolated Hypogonadotropic Hypogonadism (IHH)
Family history	Often positive for late puberty in parents or siblings	May have family history of anosmia, hypogonadism, or associated features
Anosmia/hyposmia	Absent	Present in Kallmann syndrome (~50% of IHH)
Associated features	None (aside from short stature)	May have midline defects, synkinesia, renal anomalies, hearing loss
Testicular volume (boys)	May show early increase (4-6 mL)	Often remains <4 mL or shows no increase over time
Response to GnRH stimulation test	Variable; not reliably discriminating	Variable; not reliably discriminating
Serial observation	Puberty eventually progresses spontaneously	No spontaneous pubertal progression

Key Concept: The definitive distinction between constitutional delay and permanent hypogonadotropic hypogonadism often requires observation over time. If puberty has not progressed by age 17-18 despite adequate bone age advancement, permanent hypogonadism becomes increasingly likely. Newer markers such as inhibin B, anti-Müllerian hormone (AMH), and kisspeptin stimulation testing are being studied but are not yet part of routine clinical practice.

3. History Taking

A comprehensive approach to eliciting the delayed puberty history

Red Flags — Require Urgent Evaluation

Anosmia or hyposmia — suggests Kallmann syndrome
Headaches, visual disturbances — intracranial pathology (tumor, increased intracranial pressure)
Galactorrhea — hyperprolactinemia (prolactinoma)
Severe short stature with dysmorphic features — Turner syndrome or other genetic syndrome
Chronic illness symptoms — weight loss, fatigue, abdominal pain, diarrhea

History of chemotherapy or cranial/gonadal radiation — acquired hypogonadism
Arrested puberty — puberty started but stalled for >2 years
Cryptorchidism or micropenis in boys — suggests congenital hypogonadism
Primary amenorrhea with cyclic pelvic pain — anatomical obstruction
Signs of restrictive eating or excessive exercise — functional hypothalamic suppression

Systematic History: The “DELAYED” Approach

Use the mnemonic “DELAYED” to ensure comprehensive history taking for pubertal delay:

D — Development timeline: When did puberty begin (if at all)? Any progression or stalling? Compare to siblings and peers.
E — Energy and nutrition: Eating habits, weight changes, exercise patterns, symptoms of chronic disease (fatigue, pain, diarrhea).
L — Lineage (family history): Age of puberty in parents and siblings, family history of anosmia, infertility, or genetic syndromes.
A — Associated symptoms: Headaches, vision changes, smell ability, galactorrhea, abdominal pain, learning difficulties.
Y — Years of growth: Growth pattern since childhood, previous height measurements, growth velocity, birth history.
E — Exposures and treatments: Chemotherapy, radiation, medications, chronic illnesses, surgeries (especially gonadal or cranial).
D — Distress and psychosocial impact: How is this affecting the patient? Self-esteem, peer relationships, bullying, anxiety, depression.

Detailed History Components

Pubertal Development History

Question	Rationale	What to Look For
“Have you noticed any changes in your body over the past few years?”	Open-ended assessment of pubertal awareness	Complete absence vs. partial development; patient’s perception
Boys: “Have your testicles grown larger? When did you first notice pubic hair? Any voice changes?”	Assesses sequence and timing of male pubertal milestones	Testicular enlargement should precede other changes; voice deepening is a late sign
Girls: “When did your breasts start to develop? Have you started your periods?”	Assesses sequence and timing of female pubertal milestones	Thelarche before menarche; menarche typically 2-2.5 years after breast budding
“Has your development progressed, stayed the same, or stopped?”	Distinguishes complete absence from arrested puberty	Arrested puberty has higher likelihood of pathology
“How do you compare to your friends/classmates?”	Contextualizes patient’s self-perception	Significant perceived difference may warrant earlier intervention for psychosocial reasons

Growth History

Question	Rationale	What to Look For
“Do you have previous height measurements? Growth charts from school or prior visits?”	Growth velocity is critical for assessment	Declining growth velocity suggests lack of pubertal growth spurt
“Were you always shorter than your classmates, or is this more recent?”	Distinguishes constitutional short stature from pubertal delay	CDGP: typically normal height earlier, then falls behind during expected pubertal years
“What are the heights of your parents and siblings?”	Calculates mid-parental height (genetic potential)	Mid-parental height = [(mother’s height + father’s height) ± 13 cm] / 2

Birth and Early Development History

Birth History

Gestational age and birth weight: Prematurity and SGA may affect growth and puberty
Delivery complications: Breech delivery, birth asphyxia (pituitary damage)
Neonatal problems: Prolonged jaundice, hypoglycemia, micropenis, cryptorchidism (suggest congenital hypopituitarism)
Neonatal feeding difficulties: May indicate midline defects or hypopituitarism

Developmental Milestones

Motor milestones: Gross and fine motor delays may suggest syndromes
Speech and language: Delays may be associated with genetic conditions
Learning difficulties: Consider Klinefelter syndrome, Turner syndrome
Behavioral issues: May be associated with Prader-Willi syndrome or other conditions

Family History

Critical Family History Questions

Family history is particularly important in delayed puberty because constitutional delay is strongly familial:

“At what age did the mother have her first period?” — Late menarche (≥14-15 years) suggests familial pattern
“At what age did the father start shaving or have his growth spurt?” — Late puberty in father supports CDGP
“Did any siblings have delayed puberty?” — Pattern in siblings strengthens CDGP diagnosis
“Is there anyone in the family who cannot smell or has a reduced sense of smell?” — Anosmia suggests Kallmann syndrome
“Any family history of infertility or hormone problems?” — May suggest hypogonadism
“Any family history of Turner syndrome, Klinefelter syndrome, or other genetic conditions?”

Targeted Questions by Suspected Cause

Suspected Cause	Key Features	Ask This Question
Constitutional Delay of Growth and Puberty	Family history of late puberty; otherwise healthy; short stature with delayed bone age	“Did either parent or any siblings go through puberty late? When did your mother get her period? When did your father start shaving?”
Kallmann Syndrome	Anosmia, possible midline defects, family history	“Can you smell things normally? Have you ever had difficulty smelling food, perfume, or smoke? Any hearing problems or cleft lip/palate in the family?”
Turner Syndrome	Short stature, webbed neck, cardiac/renal anomalies	“Has she had any heart murmurs or kidney problems? Any swelling of hands or feet as a baby? Frequent ear infections?”
Klinefelter Syndrome	Tall stature, learning difficulties, small testes, gynecomastia	“Any difficulties in school, especially with reading or language? Has he noticed any breast tissue development?”
Pituitary/Hypothalamic Tumor	Headaches, visual changes, other hormone deficiencies	“Any headaches, especially in the morning? Any vision problems or double vision? Excessive thirst or urination? Fatigue?”
Hyperprolactinemia	Galactorrhea, headaches, visual changes	“Have you noticed any milky discharge from your nipples? Any headaches or vision changes?”
Chronic Disease	Weight loss, fatigue, organ-specific symptoms	“Any abdominal pain, diarrhea, or blood in stool? Frequent infections? Joint pain? Difficulty breathing?”
Celiac Disease	Gastrointestinal symptoms, anemia, poor growth	“Any bloating, diarrhea, or stomach pain after eating? Does bread or pasta seem to cause problems?”
Functional Hypothalamic Amenorrhea	Low weight, restrictive eating, excessive exercise	“Tell me about your eating habits. How much do you exercise? Have you lost weight recently? Do you worry about your weight or body shape?”
Anatomical Causes (Primary Amenorrhea)	Normal breast development but absent menarche, cyclic pain	“Do you have monthly cramping or pain even without a period? Any difficulty using tampons? Any bulging at the vaginal opening?”

Review of Systems for Associated Features

System	Symptoms to Ask About	Condition Suggested
Neurological	Headaches, vision changes, diplopia, anosmia	CNS tumor, Kallmann syndrome
Gastrointestinal	Abdominal pain, diarrhea, constipation, bloating, blood in stool	Celiac disease, inflammatory bowel disease
Respiratory	Chronic cough, recurrent pneumonia, sinusitis	Cystic fibrosis, primary ciliary dyskinesia
Cardiovascular	Murmurs, exercise intolerance, chest pain	Turner syndrome (coarctation, bicuspid aortic valve)
Renal	Urinary tract infections, kidney problems	Turner syndrome, Kallmann syndrome (renal agenesis)
Endocrine	Fatigue, cold intolerance, constipation, polyuria, polydipsia	Hypothyroidism, diabetes insipidus, panhypopituitarism
Psychological	Depression, anxiety, social isolation, bullying, body image concerns	Psychosocial impact (all causes); eating disorders

Medical History and Exposures

Past Medical History

Chronic illnesses: Any condition affecting nutrition or causing inflammation
Cancer history: Type, treatment received (chemotherapy agents, radiation fields and doses)
Surgeries: Especially brain surgery, gonadal surgery, orchidopexy
Head trauma: May cause pituitary dysfunction
CNS infections: Meningitis, encephalitis
Autoimmune conditions: May be associated with autoimmune hypogonadism

Medications and Treatments

Chemotherapy: Alkylating agents (cyclophosphamide, busulfan) are highly gonadotoxic
Radiation therapy: Cranial radiation (>30 Gy affects GnRH neurons); gonadal radiation damages germ cells
Chronic corticosteroids: Can suppress the HPG axis
Opioids: Chronic use suppresses GnRH
Antipsychotics: May cause hyperprolactinemia
Anabolic steroids: Exogenous androgens suppress endogenous production

Psychosocial Assessment

Essential Psychosocial Questions

The psychosocial impact of delayed puberty is significant and should be assessed in all patients:

“How do you feel about the way your body is developing compared to your friends?”
“Has anyone at school said anything about your height or development?”
“Do you feel left out or different from your peers?”
“How is your mood? Do you ever feel sad or anxious about this?”
“Is this affecting your confidence or your activities (sports, social events)?”
“What are you most worried about regarding your development?”

Note: Consider speaking with the adolescent alone for part of the history to allow open discussion.

4. Physical Examination

A systematic approach to examining the patient with delayed puberty

Systematic Framework: The physical examination in delayed puberty serves three purposes: (1) accurately stage pubertal development, (2) assess growth parameters and body proportions, and (3) identify features suggesting specific underlying conditions. A complete examination should be performed with sensitivity to the adolescent’s privacy and comfort.

General Inspection

Overall appearance: Does the patient appear younger than stated age? Syndromic features?
Nutritional status: Thin, cachectic (chronic disease, eating disorder), or obese (Prader-Willi, Klinefelter)
Body habitus: Eunuchoid proportions (arm span > height by >5 cm; lower segment > upper segment) suggests hypogonadism before epiphyseal fusion
Affect and demeanor: Anxious, withdrawn, depressed? Signs of psychological distress?
Dysmorphic features: Suggest genetic syndromes (Turner, Klinefelter, Prader-Willi, Kallmann)

Growth Parameters

Essential Measurements

Height: Plot on growth chart; calculate height velocity if previous measurements available
Weight: Plot on growth chart; calculate BMI
BMI: Low BMI suggests nutritional deficiency or chronic disease; high BMI in certain syndromes
Arm span: Normally approximately equal to height; arm span > height by >5 cm suggests delayed epiphyseal fusion (hypogonadism)
Upper-to-lower segment ratio: Lower segment (pubic symphysis to floor) normally equals upper segment after age 10; in hypogonadism, lower segment > upper segment
Mid-parental height: Compare current height to genetic potential

Measurement	How to Measure	Normal Finding	Abnormal Finding and Significance
Height	Stadiometer, without shoes, heels together	Tracking along percentile curve appropriate for mid-parental height	Falling off growth curve or height significantly below genetic potential
Weight	Calibrated scale, light clothing	Appropriate for height	Underweight (chronic disease, eating disorder); obesity (some syndromes)
Arm Span	Fingertip to fingertip with arms outstretched horizontally	Within 5 cm of height	Arm span > height by >5 cm = eunuchoid proportions (hypogonadism)
Upper Segment	Top of head to pubic symphysis (sitting height)	Approximately equal to lower segment after age 10	Upper segment < lower segment = eunuchoid proportions
Lower Segment	Pubic symphysis to floor (height minus sitting height)	Approximately equal to upper segment after age 10	Increased lower segment suggests delayed epiphyseal fusion

Pubertal Staging (Tanner Staging)

Accurate Tanner staging is the cornerstone of the physical examination. Document both genital/breast stage and pubic hair stage separately, as they may be discordant.

Boys: Genital Examination

Tanner Stage	Testicular Volume	Genital Description	Clinical Notes
G1 (Prepubertal)	<4 mL (or <2.5 cm length)	Childlike penis and scrotum	No pubertal development
G2	4-8 mL (2.5-3.2 cm)	Scrotum enlarges, skin thins and reddens; minimal penile growth	First sign of puberty; often subtle
G3	8-12 mL (3.3-4.0 cm)	Penis lengthens; continued scrotal growth	Penis growth becomes noticeable
G4	12-15 mL (4.1-4.5 cm)	Penis grows in length and width; glans develops; scrotum darkens	Approaching adult appearance
G5 (Adult)	>15-25 mL (>4.5 cm)	Adult genitalia	Full maturation

Measuring Testicular Volume

Use a Prader orchidometer (series of calibrated ellipsoid beads) to estimate testicular volume by comparison. Alternatively, measure testicular length with a ruler (length ≥2.5 cm or volume ≥4 mL indicates onset of puberty).

Key point: Testicular volume <4 mL in a boy over age 14 confirms delayed puberty. Serial measurements showing no increase over 6-12 months raise concern for permanent hypogonadism.

Girls: Breast Examination

Tanner Stage	Breast Description	Clinical Notes
B1 (Prepubertal)	No glandular tissue; areola flat	No breast development
B2 (Breast bud)	Breast bud palpable; areola widens; small mound	First sign of puberty (thelarche)
B3	Breast and areola enlarge; no contour separation	Continued growth
B4	Areola and papilla form secondary mound above breast	May not occur in all individuals
B5 (Adult)	Mature breast; areola recedes to breast contour; papilla projects	Full maturation

Pubic Hair (Both Sexes)

Tanner Stage	Description	Clinical Notes
PH1	No pubic hair (may have vellus hair)	Prepubertal
PH2	Sparse, slightly pigmented hair at base of penis/labia majora	Adrenarche contribution; may precede gonadarche
PH3	Darker, coarser, curlier hair spreading over pubis	Progressive development
PH4	Adult-type hair, limited area, not reaching thighs	Near-adult pattern
PH5	Adult distribution extending to medial thighs	Full maturation (may extend further with age)

Important Note: Adrenarche vs. Gonadarche

Pubic and axillary hair development (adrenarche) is driven by adrenal androgens and is independent of gonadal function. Therefore:

A patient may have pubic hair (PH2-3) but no breast development or testicular enlargement — this indicates adrenarche without gonadarche
The presence of pubic hair does NOT rule out hypogonadism
Focus on gonadal signs (testicular volume in boys, breast development in girls) to assess HPG axis function

Syndrome-Specific Physical Findings

Turner Syndrome (45,X and Variants)

Classic Features

Short stature (typically <150 cm adult height)
Webbed neck (pterygium colli)
Low posterior hairline
Shield chest with widely spaced nipples
Cubitus valgus (increased carrying angle)
Short 4th metacarpal

Associated Findings

Lymphedema of hands/feet (especially in infancy)
Multiple pigmented nevi
High-arched palate
Recurrent otitis media, hearing loss
Cardiac murmur (coarctation, bicuspid aortic valve)
Hypertension (renal artery stenosis or coarctation)

Klinefelter Syndrome (47,XXY)

Classic Features

Tall stature with long legs
Eunuchoid body proportions
Small, firm testes (typically <4 mL even after puberty)
Gynecomastia (30-50%)
Decreased facial and body hair
Female pattern pubic hair distribution

Associated Findings

Learning difficulties (especially verbal processing)
Behavioral and psychological issues
Clinodactyly
Obesity and metabolic syndrome (later life)
Note: Many individuals are phenotypically normal

Kallmann Syndrome

Classic Features

Anosmia or hyposmia — test with non-irritating scents (coffee, vanilla, peppermint)
Absent or incomplete puberty
Eunuchoid proportions (if untreated)
Micropenis (may be present from birth)
Cryptorchidism (30%)

Associated Findings

Synkinesia (mirror movements) — ask patient to tap fingers on one hand while keeping other still
Cleft lip or palate
Dental agenesis
Hearing loss (sensorineural)
Renal agenesis (unilateral)
Color blindness

Prader-Willi Syndrome

Classic Features

Obesity (hyperphagia begins in childhood)
Short stature
Small hands and feet
Hypotonia (especially in infancy)
Hypogonadism (cryptorchidism, small penis in boys; hypoplastic labia in girls)

Associated Findings

Intellectual disability (mild to moderate)
Characteristic facies (almond-shaped eyes, narrow bifrontal diameter, thin upper lip)
Behavioral problems (temper tantrums, obsessive-compulsive features)
Sleep disturbances
Skin picking

System-Specific Examination

Head and Neck

Examination	Finding	Significance
Visual fields	Bitemporal hemianopia	Pituitary or suprasellar tumor (compressing optic chiasm)
Fundoscopy	Papilledema, optic atrophy	Increased intracranial pressure, prior optic nerve damage
Smell testing	Anosmia or hyposmia	Kallmann syndrome
Neck inspection	Webbing, low hairline	Turner syndrome
Thyroid palpation	Goiter or atrophic thyroid	Thyroid disease (can affect puberty)
Midline defects	Cleft lip/palate (or repaired), single central incisor	Midline defects associated with septo-optic dysplasia, Kallmann syndrome

Chest and Cardiovascular

Finding	Description	Associated Condition
Gynecomastia	Palpable breast tissue in males	Klinefelter syndrome, hyperprolactinemia, liver disease
Galactorrhea	Milky nipple discharge	Hyperprolactinemia (prolactinoma, medications)
Shield chest	Broad chest with widely spaced nipples	Turner syndrome
Cardiac murmur	Systolic murmur, radiofemoral delay	Coarctation of aorta (Turner syndrome)
Hypertension	Blood pressure above 95th percentile for age	Coarctation, renal artery stenosis (Turner syndrome)

Abdomen and Pelvis

Abdominal scars: Previous surgery (may indicate underlying condition)
Hepatomegaly: Chronic liver disease
Palpable kidneys: Polycystic kidney disease (unilateral absence in Kallmann syndrome cannot be detected on exam)
Inguinal region: Check for inguinal hernia (may contain gonad in disorders of sex development)

External Genitalia (with consent and chaperone)

Boys

Testicular position: Descended, retractile, or cryptorchid
Testicular size: Use orchidometer; <4 mL at age >14 = delayed puberty
Testicular consistency: Small, firm testes suggest Klinefelter
Penile size: Micropenis (<2.5 cm stretched length at birth; <9.5 cm adult) suggests hypogonadism
Hypospadias: May suggest disorders of sex development

Girls

External inspection: Assess clitoromegaly (androgen excess), hypoplastic labia
Vaginal patency: If primary amenorrhea with normal breast development — assess for imperforate hymen (bulging membrane) or vaginal agenesis
Note: Internal pelvic examination is generally not required in initial evaluation; pelvic ultrasound preferred

Extremities and Skin

Finding	Description	Associated Condition
Cubitus valgus	Increased carrying angle (>15°)	Turner syndrome
Short 4th metacarpal	Dimple over 4th knuckle when making a fist	Turner syndrome, pseudohypoparathyroidism
Lymphedema	Swelling of hands or feet (history or current)	Turner syndrome (especially in infancy)
Small hands and feet	Disproportionately small relative to body size	Prader-Willi syndrome
Synkinesia	Mirror movements (involuntary movement of one hand when the other moves)	Kallmann syndrome
Multiple nevi	Many pigmented moles	Turner syndrome

Summary: Expected Findings by Etiology

Condition	Growth	Pubertal Stage	Distinctive Physical Findings
Constitutional Delay	Short for age; delayed bone age	G1/B1 or early G2/B2	No syndromic features; otherwise normal exam
Kallmann Syndrome	May have eunuchoid proportions	G1/B1; micropenis, cryptorchidism in males	Anosmia; synkinesia; midline defects possible
Isolated GnRH Deficiency	May have eunuchoid proportions	G1/B1	No anosmia; otherwise similar to Kallmann
Turner Syndrome	Short stature	B1 or partial B2 (30% may have some development)	Webbed neck, shield chest, cubitus valgus, cardiac findings
Klinefelter Syndrome	Tall, eunuchoid proportions	May reach G3-G4 then stall; small firm testes	Gynecomastia; learning difficulties; behavioral issues
Prader-Willi Syndrome	Short stature; obese	G1/B1 with cryptorchidism	Obesity, hypotonia, small hands/feet, characteristic facies
Functional (Undernutrition)	Low BMI; may be short	G1/B1 or arrested	Thin, lanugo hair (anorexia), signs of chronic disease
Pituitary Tumor	Variable	G1/B1 or arrested	Visual field defects; may have other hormone deficiencies

Important Teaching Point

A completely normal physical examination is common in constitutional delay of growth and puberty. These patients have no syndromic features, normal body proportions (although short for age), and prepubertal or early pubertal findings appropriate for their delayed bone age. The absence of abnormal findings does not rule out pathology but makes constitutional delay more likely. Serial examinations showing pubertal progression over time help confirm this diagnosis.

5. Differential Diagnosis

Systematic approach organized by probability, mechanism, and clinical features

The differential diagnosis of delayed puberty is organized by the underlying mechanism: constitutional delay (a normal variant), hypogonadotropic hypogonadism (central causes with low gonadotropins), and hypergonadotropic hypogonadism (gonadal causes with elevated gonadotropins). This distinction is fundamental because it determines further workup and management.

Step-by-Step Approach to Delayed Puberty:

Step 1: Confirm delayed puberty — verify absence of pubertal signs at appropriate age thresholds (no testicular enlargement by age 14 in boys; no breast development by age 13 in girls)
Step 2: Obtain baseline hormones — measure LH, FSH, and sex steroids to classify as hypogonadotropic or hypergonadotropic
Step 3: Assess for red flags — anosmia, headaches, visual changes, chronic disease symptoms, syndromic features
Step 4: Review growth pattern and family history — delayed bone age with family history of late puberty suggests constitutional delay
Step 5: Targeted workup based on classification — karyotype if hypergonadotropic; MRI and additional pituitary hormones if hypogonadotropic with red flags

Overview of Differential Diagnosis by Mechanism

Category	Gonadotropins	Frequency	Key Conditions
Constitutional Delay of Growth and Puberty	Low (prepubertal) → Normal	50-65% (boys), 25-30% (girls)	Normal variant; diagnosis of exclusion
Functional Hypogonadotropic Hypogonadism	Low	15-20% (more common in girls)	Chronic disease, undernutrition, excessive exercise, stress
Permanent Hypogonadotropic Hypogonadism	Low	10-15%	Kallmann syndrome, isolated GnRH deficiency, pituitary disorders
Hypergonadotropic Hypogonadism	High	10-25%	Turner syndrome, Klinefelter syndrome, gonadal dysgenesis, acquired gonadal damage

Detailed Differential: Hypogonadotropic Hypogonadism (Low LH/FSH)

Low or inappropriately normal gonadotropins indicate a problem at the level of the hypothalamus or pituitary, or a functional suppression of the hypothalamic-pituitary-gonadal axis.

Probability	Condition	Key Features	Distinguishing Clues
COMMON	Constitutional Delay of Growth and Puberty	Family history of late puberty; short stature with delayed bone age; otherwise healthy	Parent or sibling with late puberty; no red flags; eventual spontaneous progression
COMMON	Functional (Chronic Disease)	Underlying illness: celiac disease, inflammatory bowel disease, cystic fibrosis, chronic kidney disease, sickle cell disease	Symptoms of underlying disease; low BMI; elevated inflammatory markers; improves with disease control
COMMON (girls)	Functional Hypothalamic Amenorrhea	Low body weight, restrictive eating, excessive exercise, psychological stress	Low BMI; history of dieting or intense athletic training; reversible with weight restoration
LESS COMMON	Kallmann Syndrome	Congenital GnRH deficiency with anosmia; may have midline defects, synkinesia, renal anomalies	Anosmia or hyposmia on testing; family history; absent olfactory bulbs on MRI
LESS COMMON	Isolated Hypogonadotropic Hypogonadism (without anosmia)	Congenital GnRH deficiency with normal sense of smell	No anosmia; otherwise similar to Kallmann; genetic testing may identify mutations
LESS COMMON	Hyperprolactinemia	Elevated prolactin suppresses GnRH; may be due to prolactinoma or medications	Galactorrhea; headaches; elevated prolactin level; MRI shows pituitary adenoma
LESS COMMON	Hypothyroidism (Severe)	Severe primary hypothyroidism can delay puberty	Fatigue, constipation, cold intolerance, goiter; elevated TSH, low free T4
UNCOMMON BUT SERIOUS	Pituitary or Hypothalamic Tumor	Craniopharyngioma, germinoma, pituitary adenoma, optic glioma	Headaches, visual field defects, other pituitary hormone deficiencies, diabetes insipidus
UNCOMMON BUT SERIOUS	Cranial Irradiation	History of CNS tumor treatment; radiation >30 Gy damages hypothalamus	Known oncology history; may have multiple pituitary deficiencies
UNCOMMON	Prader-Willi Syndrome	Hypothalamic dysfunction; obesity, hypotonia, intellectual disability	Characteristic phenotype; neonatal hypotonia; hyperphagia; genetic testing confirms
UNCOMMON	Septo-Optic Dysplasia	Optic nerve hypoplasia, midline brain defects, pituitary dysfunction	Visual impairment; nystagmus; may have other pituitary deficiencies
UNCOMMON	Combined Pituitary Hormone Deficiency	Multiple pituitary hormone deficiencies including gonadotropins	Short stature (GH deficiency), hypothyroidism, adrenal insufficiency; often diagnosed earlier

Detailed Differential: Hypergonadotropic Hypogonadism (High LH/FSH)

Elevated gonadotropins indicate primary gonadal failure. The pituitary is responding appropriately to low sex steroid feedback by increasing LH and FSH secretion.

Probability	Condition	Sex	Key Features	Distinguishing Clues
COMMON	Turner Syndrome (45,X and variants)	Female	Short stature, streak gonads, cardiac and renal anomalies	Classic phenotype (webbed neck, shield chest); karyotype confirms; ~1:2500 females
COMMON	Klinefelter Syndrome (47,XXY)	Male	Tall stature, small firm testes, gynecomastia, learning difficulties	Small testes despite some pubertal progression; karyotype confirms; ~1:500-1000 males
LESS COMMON	46,XX Gonadal Dysgenesis (Swyer-like in 46,XX)	Female	Primary amenorrhea, streak gonads, normal stature	Normal female phenotype and stature (unlike Turner); karyotype 46,XX
LESS COMMON	46,XY Gonadal Dysgenesis (Swyer Syndrome)	46,XY phenotypic female	Female phenotype with streak gonads; presents with primary amenorrhea	Phenotypic female with 46,XY karyotype; streak gonads require removal (malignancy risk)
LESS COMMON	Chemotherapy-Induced Gonadal Failure	Both	History of cancer treatment, especially alkylating agents	Known oncology history; cyclophosphamide, busulfan most gonadotoxic
LESS COMMON	Radiation-Induced Gonadal Failure	Both	History of pelvic or gonadal irradiation	Known radiation history; dose-dependent damage
UNCOMMON	Autoimmune Oophoritis/Orchitis	Both	May be associated with autoimmune polyendocrine syndrome	Other autoimmune conditions present (Addison disease, thyroiditis, type 1 diabetes)
UNCOMMON	Bilateral Cryptorchidism (with atrophic testes)	Male	History of undescended testes, failed orchidopexy, or anorchia	History of cryptorchidism; absent or atrophic testes
UNCOMMON	Gonadal Torsion or Trauma	Male	History of bilateral testicular injury or torsion	History of acute scrotal event
UNCOMMON	Galactosemia	Female	Toxic metabolites damage ovaries; often diagnosed in infancy	Known metabolic disorder; hypergonadotropic despite dietary treatment
UNCOMMON	Noonan Syndrome	Both (more severe in males)	Short stature, webbed neck (Turner-like), cardiac defects, cryptorchidism in males	Both sexes affected; normal karyotype; RASopathy genes; males may have cryptorchidism

Anatomical Approach to Differential Diagnosis

Hypothalamus

Constitutional delay

Kallmann syndrome

Isolated GnRH deficiency

Functional suppression (nutrition, stress)

Prader-Willi syndrome

Septo-optic dysplasia

Craniopharyngioma

Cranial irradiation

Pituitary

Combined pituitary hormone deficiency

Pituitary adenoma (prolactinoma)

Pituitary hypoplasia/aplasia

Post-surgical hypopituitarism

Hemochromatosis (rare in pediatrics)

Hypophysitis

Gonads (Ovaries)

Turner syndrome (45,X)

46,XX gonadal dysgenesis

46,XY gonadal dysgenesis (Swyer)

Chemotherapy damage

Radiation damage

Autoimmune oophoritis

Galactosemia

Resistant ovary syndrome

Gonads (Testes)

Klinefelter syndrome (47,XXY)

Bilateral cryptorchidism/anorchia

Chemotherapy damage

Radiation damage

Bilateral torsion or trauma

Noonan syndrome (variable)

Myotonic dystrophy

Autoimmune orchitis

Primary Amenorrhea: Special Considerations

In girls presenting with primary amenorrhea (no menarche by age 15-16 with breast development, or by age 13-14 without breast development), additional anatomical causes must be considered:

Category	Condition	Breast Development	Key Features
Outflow Obstruction	Imperforate hymen	Present (normal)	Cyclic pelvic pain, bulging hymen, hematocolpos on ultrasound
Outflow Obstruction	Transverse vaginal septum	Present (normal)	Cyclic pain, hematocolpos; septum may be high or low
Müllerian Agenesis	Mayer-Rokitansky-Küster-Hauser Syndrome	Present (normal)	Absent uterus and upper vagina; normal ovaries; 46,XX karyotype; may have renal anomalies
Androgen Insensitivity	Complete Androgen Insensitivity Syndrome	Present (normal)	46,XY karyotype; female phenotype; absent uterus; testes (often inguinal); sparse pubic/axillary hair

Clinical Pearl: Breast Development as a Key Branch Point

In girls with primary amenorrhea, the presence or absence of breast development is a critical branch point:

Breasts ABSENT: Indicates lack of estrogen → hypogonadism (either hypogonadotropic or hypergonadotropic)
Breasts PRESENT: Indicates estrogen exposure → consider anatomical causes (outflow obstruction, Müllerian agenesis), androgen insensitivity, or late-onset hypogonadism

Drug-Induced Causes of Delayed Puberty

Drug or Drug Class	Mechanism	Reversibility	Clinical Notes
Chronic Glucocorticoids	Suppress GnRH pulsatility; direct gonadal effects	Usually reversible after discontinuation	Also suppresses growth; seen in chronic asthma, autoimmune diseases, post-transplant
Chemotherapy (Alkylating Agents)	Direct gonadal toxicity; damage to germ cells and steroidogenic cells	Often permanent (dose-dependent)	Cyclophosphamide, busulfan, procarbazine most gonadotoxic; consider fertility preservation
Gonadal Irradiation	Direct gonadal damage	Permanent if high dose	Dose-dependent; ovaries more radiosensitive; testicular Leydig cells more resistant than germ cells
Cranial Irradiation (>30 Gy)	Damages hypothalamic GnRH neurons	Usually permanent	May cause precocious puberty at lower doses; hypogonadism at higher doses
Chronic Opioid Use	Suppresses GnRH secretion	Reversible after discontinuation	Consider in adolescents with chronic pain or substance use
Antipsychotics (Dopamine Antagonists)	Cause hyperprolactinemia, which suppresses GnRH	Reversible with dose reduction or switching agent	Risperidone, haloperidol most likely; check prolactin level
GnRH Agonists (Therapeutic)	Downregulate GnRH receptors after initial stimulation	Reversible after discontinuation	Used intentionally for precocious puberty or gender-affirming care
Anabolic Steroids	Exogenous androgens suppress endogenous HPG axis	Usually reversible; may cause prolonged suppression	Consider in male athletes or adolescents seeking muscle gain

Quick Reference: “If You See This, Think This”

Clinical Clue	Think This First	Next Step
Family history of late puberty + short stature + delayed bone age	Constitutional delay of growth and puberty	Reassurance; may offer short course of sex steroids for psychosocial benefit
Anosmia or hyposmia	Kallmann syndrome	MRI (olfactory bulbs); genetic testing; hormone replacement
Short girl + webbed neck + shield chest	Turner syndrome	Karyotype; cardiac and renal imaging; growth hormone + estrogen therapy
Tall boy + small firm testes + gynecomastia	Klinefelter syndrome	Karyotype; testosterone replacement; fertility counseling
Headaches + visual field defects	Pituitary or hypothalamic tumor	Urgent MRI brain with pituitary protocol; check all pituitary hormones
Galactorrhea	Hyperprolactinemia (prolactinoma or medication-induced)	Prolactin level; if elevated, MRI pituitary; review medications
Low BMI + restrictive eating + excessive exercise (girl)	Functional hypothalamic amenorrhea	Nutritional rehabilitation; psychological support; monitor bone density
Chronic abdominal symptoms + poor growth	Celiac disease or inflammatory bowel disease	Celiac serology (TTG-IgA); consider gastroenterology referral
History of chemotherapy or cranial radiation	Acquired hypogonadism (central or gonadal depending on treatment)	Check LH, FSH, sex steroids; MRI if central cause suspected
Obesity + hypotonia + intellectual disability + small hands/feet	Prader-Willi syndrome	Genetic testing (methylation analysis); multidisciplinary management
Primary amenorrhea + normal breasts + cyclic pelvic pain	Outflow obstruction (imperforate hymen, transverse septum)	Pelvic examination; pelvic ultrasound; surgical correction
Primary amenorrhea + normal breasts + absent uterus	Müllerian agenesis (MRKH) or Complete Androgen Insensitivity Syndrome	Karyotype (46,XX = MRKH; 46,XY = CAIS); pelvic MRI

6. Diagnostic Investigations

A stepwise, targeted approach guided by clinical suspicion

The investigation of delayed puberty should be systematic and targeted based on clinical findings. The initial workup classifies the patient as having hypogonadotropic or hypergonadotropic hypogonadism, which then directs further testing.

First-Line Investigations for All Patients

Investigation	Purpose	What to Look For	Clinical Notes
LH and FSH	Classify as hypogonadotropic or hypergonadotropic	Low/prepubertal = central cause; Elevated = gonadal cause	Draw in morning; single sample often sufficient for initial classification
Testosterone (boys) or Estradiol (girls)	Confirm hypogonadism	Low levels confirm deficiency	Morning testosterone preferred in boys (diurnal variation)
Bone Age (Left Hand and Wrist X-ray)	Assess skeletal maturity	Delayed bone age suggests constitutional delay or chronic illness	Bone age >2 years behind chronological age is significant; predicts remaining growth potential
Complete Blood Count	Screen for chronic disease, anemia	Anemia, elevated platelets (chronic inflammation)	Microcytic anemia may suggest celiac disease or IBD
Comprehensive Metabolic Panel	Screen for renal, hepatic disease; electrolytes	Elevated creatinine (CKD), liver abnormalities, electrolyte disturbances	Basic screening for systemic disease
Erythrocyte Sedimentation Rate and/or C-Reactive Protein	Screen for chronic inflammation	Elevated in IBD, chronic infection, autoimmune disease	May be normal in celiac disease despite active inflammation
Thyroid Function Tests (TSH, Free T4)	Screen for hypothyroidism	Elevated TSH, low free T4 = primary hypothyroidism	Severe hypothyroidism can delay puberty; mild cases usually do not
Celiac Serology (Tissue Transglutaminase IgA, Total IgA)	Screen for celiac disease	Elevated TTG-IgA (ensure IgA sufficient)	Celiac disease is common and often occult; important treatable cause
Prolactin	Screen for hyperprolactinemia	Elevated prolactin suppresses GnRH	If elevated, consider prolactinoma or medication effect

Interpreting Gonadotropins:

Prepubertal/Low LH and FSH + Low Sex Steroids: Hypogonadotropic hypogonadism — problem is at hypothalamus or pituitary (or physiological in constitutional delay)
Elevated LH and FSH + Low Sex Steroids: Hypergonadotropic hypogonadism — primary gonadal failure
Note: “Prepubertal” gonadotropin levels may be reported as low or even undetectable; this does not distinguish constitutional delay from permanent hypogonadotropic hypogonadism

Second-Line Investigations Based on Classification

If Hypergonadotropic Hypogonadism (Elevated LH/FSH)

Investigation	Purpose	What to Look For	When to Order
Karyotype	Diagnose chromosomal abnormalities	45,X or variants (Turner); 47,XXY (Klinefelter); 46,XY in phenotypic female (Swyer)	All patients with hypergonadotropic hypogonadism
Pelvic Ultrasound (girls)	Assess uterus and ovaries	Streak gonads (Turner, gonadal dysgenesis); absent uterus (MRKH, CAIS)	All girls with hypergonadotropic hypogonadism or primary amenorrhea
Echocardiogram (if Turner suspected)	Screen for cardiac anomalies	Bicuspid aortic valve, coarctation, aortic root dilation	All patients with confirmed or suspected Turner syndrome
Renal Ultrasound (if Turner suspected)	Screen for renal anomalies	Horseshoe kidney, duplicated collecting system, renal agenesis	All patients with confirmed or suspected Turner syndrome
Anti-Müllerian Hormone (AMH)	Assess ovarian reserve	Very low or undetectable suggests severe ovarian failure	May help predict likelihood of spontaneous puberty in Turner variants
Autoimmune Markers	Screen for autoimmune polyglandular syndrome	Adrenal antibodies, thyroid antibodies, ovarian antibodies	If autoimmune oophoritis/orchitis suspected; other autoimmune conditions present

If Hypogonadotropic Hypogonadism (Low/Normal LH and FSH)

Investigation	Purpose	What to Look For	When to Order
MRI Brain with Pituitary Protocol	Evaluate hypothalamus and pituitary	Tumor (craniopharyngioma, germinoma, adenoma), pituitary hypoplasia, absent pituitary stalk, absent olfactory bulbs (Kallmann)	All patients with confirmed hypogonadotropic hypogonadism; urgent if headaches or visual symptoms
Full Pituitary Hormone Panel	Screen for multiple pituitary deficiencies	IGF-1 (GH axis), free T4/TSH (thyroid), morning cortisol or ACTH stimulation test (adrenal)	All patients with structural pituitary abnormality; suspected combined pituitary hormone deficiency
Formal Smell Testing	Confirm anosmia/hyposmia	Reduced ability to identify odors (e.g., UPSIT)	Suspected Kallmann syndrome; all males with isolated hypogonadotropic hypogonadism
Genetic Testing	Identify causative mutations	KAL1, FGFR1, PROKR2, GNRHR, KISS1R, and others	Confirmed permanent hypogonadotropic hypogonadism; family counseling; increasingly used in clinical practice
Inhibin B and AMH (boys)	Assess Sertoli cell function	Low inhibin B suggests gonadal dysfunction; may help predict testicular function	Research use; may help distinguish constitutional delay from permanent IHH

Investigations for Specific Clinical Scenarios

Primary Amenorrhea with Breast Development

Essential Tests

Pelvic ultrasound: Assess for uterus, vagina, ovaries; look for hematocolpos
Karyotype: Rule out 46,XY (Complete Androgen Insensitivity Syndrome, Swyer syndrome)
LH, FSH, estradiol: Hormonal status
Testosterone: Elevated in CAIS

Additional Tests as Indicated

Pelvic MRI: Better delineation of anatomy if ultrasound inconclusive
Examination under anesthesia: If vaginal anatomy unclear
Renal ultrasound: MRKH syndrome associated with renal anomalies

Suspected Constitutional Delay

Minimal Workup for Suspected Constitutional Delay

If clinical features strongly suggest constitutional delay (positive family history, otherwise healthy, no red flags), a minimal workup may be appropriate:

LH, FSH, testosterone/estradiol (confirm prepubertal status)
Bone age (confirm delayed skeletal maturity)
CBC, CMP, ESR (screen for occult chronic disease)
TSH, free T4 (screen for hypothyroidism)
Celiac serology (screen for celiac disease)

Key: Serial follow-up every 6-12 months to document pubertal progression confirms the diagnosis retrospectively.

Distinguishing Constitutional Delay from Permanent Hypogonadotropic Hypogonadism

This remains one of the most challenging diagnostic problems. No single test reliably differentiates these conditions. Several approaches have been studied:

Test	What It Measures	Findings Favoring CDGP	Findings Favoring Permanent IHH	Limitations
GnRH Stimulation Test	Pituitary LH/FSH response to exogenous GnRH	Pubertal LH response (>5-10 IU/L)	Absent or prepubertal LH response	Significant overlap; poor sensitivity and specificity; largely abandoned
Inhibin B	Sertoli cell function (boys)	Detectable levels (>35 pg/mL)	Undetectable or very low (<35 pg/mL)	Better than GnRH test but still imperfect; not widely standardized
AMH (Anti-Müllerian Hormone)	Sertoli cell function (boys)	Detectable levels	Very low or undetectable	Promising marker; combined with inhibin B improves accuracy
Kisspeptin Stimulation Test	GnRH neuron responsiveness	LH response to kisspeptin	Absent LH response	Research tool; not clinically available; shows promise
Priming with Sex Steroids + Repeat GnRH Test	Whether priming awakens the HPG axis	Improved LH response after priming	Persistently blunted response	Requires repeat testing; some overlap remains
Observation Over Time	Natural pubertal progression	Puberty progresses spontaneously	No pubertal progression by age 17-18	The gold standard but requires prolonged waiting

Clinical Pearl: Trial of Sex Steroid Therapy

A practical approach is to offer a short course of low-dose sex steroids (e.g., testosterone for boys, estrogen for girls) for 3-6 months, then discontinue and observe:

Constitutional delay: Endogenous puberty continues after stopping treatment (“kickstarting” effect)
Permanent hypogonadism: Puberty stalls or regresses after stopping treatment, confirming need for ongoing therapy

This approach provides psychosocial benefit while serving as a diagnostic tool.

Reference Values

Gonadotropin Interpretation

Stage	LH (IU/L)	FSH (IU/L)	Interpretation
Prepubertal	<0.3-1.0	<1.0-3.0	Normal for prepubertal child; also seen in hypogonadotropic states
Early Pubertal	1.0-5.0	2.0-6.0	Puberty initiating; may see nocturnal LH pulses first
Mid-Late Pubertal	2.0-12.0	3.0-10.0	Active puberty
Elevated (Hypergonadotropic)	>10-15	>10-15	Primary gonadal failure; especially if prepubertal sex steroids

Note: Reference ranges vary by assay; interpret in context of laboratory-specific ranges.

Sex Steroid Interpretation

Hormone	Prepubertal	Early Pubertal	Adult Range
Testosterone (boys)	<20 ng/dL	20-150 ng/dL	300-1000 ng/dL
Estradiol (girls)	<10 pg/mL	10-50 pg/mL	30-400 pg/mL (varies with cycle)

Investigation Algorithm Summary

Step 1: Initial Classification

Obtain LH, FSH, testosterone (boys) or estradiol (girls)
Obtain bone age
Basic screening labs (CBC, CMP, TSH, celiac serology, ESR)

Step 2: Branch by Gonadotropin Level

If LH/FSH elevated: Karyotype → Pelvic ultrasound (girls) → Consider cardiac/renal imaging if Turner suspected
If LH/FSH low/normal: MRI brain with pituitary protocol → Full pituitary panel → Smell testing → Consider genetic testing

Step 3: If Constitutional Delay Suspected

Minimal workup as above
Serial follow-up every 6-12 months
Consider short-term sex steroid trial for psychosocial benefit and diagnostic purposes

7. Clinical Decision-Making

Practical algorithms and decision pathways for managing delayed puberty

Step 1: Is This Urgent?

Most cases of delayed puberty are not emergencies, but certain presentations require urgent evaluation.

Clinical Scenario	Urgency Level	Immediate Action
Headaches + visual field defects + delayed puberty	EMERGENT	Urgent MRI brain; neurosurgery consultation; check all pituitary hormones including cortisol
Primary amenorrhea + cyclic pelvic pain + bulging hymen	EMERGENT	Pelvic ultrasound; gynecology referral for surgical drainage of hematocolpos
Signs of adrenal insufficiency (fatigue, hypotension, hypoglycemia)	EMERGENT	Morning cortisol or ACTH stimulation test; if suspected, treat empirically with hydrocortisone
Severe undernutrition with bradycardia or electrolyte abnormalities	URGENT	Medical stabilization; cardiac monitoring; refeeding protocol; psychiatric evaluation
Newly diagnosed Turner syndrome	URGENT	Cardiac imaging (coarctation, bicuspid valve); renal ultrasound; initiate growth hormone if appropriate
Significant psychological distress, suicidal ideation	URGENT	Mental health assessment; consider expedited treatment for psychosocial benefit
Delayed puberty without red flags, stable patient	ROUTINE	Outpatient endocrinology referral; initiate workup; reassurance

Step 2: Classify by Gonadotropin Level

Low or Prepubertal LH/FSH

= Hypogonadotropic Hypogonadism

Problem is at hypothalamus or pituitary (or physiological delay)

Proceed to Algorithm A

Elevated LH/FSH

= Hypergonadotropic Hypogonadism

Problem is at the gonads (primary gonadal failure)

Proceed to Algorithm B

Step 3: Follow the Appropriate Algorithm

Algorithm A: Hypogonadotropic Hypogonadism (Low LH/FSH)

Clinical Scenario	Most Likely Diagnosis	Action
Family history of late puberty + delayed bone age + no red flags + otherwise healthy	Constitutional Delay of Growth and Puberty	Reassurance; offer short-term sex steroid therapy for psychosocial benefit; follow every 6-12 months
Anosmia or hyposmia present	Kallmann Syndrome	MRI (confirm absent olfactory bulbs); genetic testing; initiate hormone replacement; fertility counseling for future
No anosmia but no family history and no pubertal progression	Isolated Hypogonadotropic Hypogonadism	MRI brain; genetic testing; hormone replacement; distinguish from CDGP over time
Headaches, visual symptoms, or other pituitary deficiencies	Pituitary/Hypothalamic Tumor	Urgent MRI; full pituitary panel; neurosurgery/oncology referral
Galactorrhea or elevated prolactin	Hyperprolactinemia	MRI pituitary; if prolactinoma, dopamine agonist therapy (cabergoline); review medications
Low BMI, restrictive eating, excessive exercise	Functional Hypothalamic Amenorrhea	Nutritional rehabilitation; psychological support; treat underlying eating disorder; monitor bone density
Symptoms of chronic disease (GI, respiratory, fatigue)	Functional (Secondary to Chronic Disease)	Identify and treat underlying condition; puberty typically progresses with disease control
History of cranial irradiation or CNS tumor treatment	Acquired Hypogonadotropic Hypogonadism	Full pituitary evaluation; hormone replacement as needed; monitor for evolving deficiencies
Obesity + hypotonia + intellectual disability + characteristic features	Prader-Willi Syndrome	Genetic testing; multidisciplinary management; sex steroid therapy; growth hormone if indicated

Algorithm B: Hypergonadotropic Hypogonadism (High LH/FSH)

Clinical Scenario	Most Likely Diagnosis	Action
Short female + characteristic features (webbed neck, shield chest)	Turner Syndrome	Karyotype to confirm; cardiac echo + renal ultrasound; growth hormone therapy; estrogen for pubertal induction
Short female without classic features but elevated FSH	Turner Syndrome (Mosaic) or 46,XX Gonadal Dysgenesis	Karyotype; pelvic ultrasound; cardiac/renal screening; hormone replacement
Tall male + small firm testes + gynecomastia + learning difficulties	Klinefelter Syndrome	Karyotype to confirm; testosterone replacement starting in early puberty; fertility counseling
Phenotypic female with primary amenorrhea + absent uterus on ultrasound	Complete Androgen Insensitivity Syndrome (if 46,XY) or MRKH (if 46,XX)	Karyotype is essential; if 46,XY, plan for gonadectomy (malignancy risk); psychological support
History of gonadotoxic chemotherapy	Chemotherapy-Induced Gonadal Failure	Hormone replacement; fertility counseling (discuss prior sperm/oocyte cryopreservation if done)
History of pelvic or gonadal radiation	Radiation-Induced Gonadal Failure	Hormone replacement; fertility assessment; monitor for other late effects
History of bilateral cryptorchidism or testicular torsion/trauma	Acquired Anorchia or Testicular Atrophy	Testosterone replacement; testicular prostheses if desired; fertility is not possible without viable testes

“What Do I Do If…” Decision Reference

Clinical Situation	Immediate Action	Next Step
Patient and family are very anxious about delayed development	Provide reassurance and education about normal variation	Offer short-term low-dose sex steroid therapy even if constitutional delay likely; address psychosocial concerns
Cannot distinguish constitutional delay from permanent hypogonadism	Offer 3-6 month trial of low-dose sex steroids	Discontinue and observe; if puberty continues = CDGP; if regresses = permanent hypogonadism needing ongoing treatment
Turner syndrome confirmed — when to start estrogen?	Start low-dose estrogen around age 11-12 (or when GH therapy well established)	Gradually increase dose over 2-3 years; add progestin when breakthrough bleeding occurs or after 2 years of estrogen
Klinefelter syndrome — when to start testosterone?	Start low-dose testosterone when LH/FSH begin to rise (typically early-mid puberty)	Monitor levels and increase gradually to adult replacement doses; discuss fertility preservation options early
Girl with primary amenorrhea but normal breast development	Pelvic ultrasound to assess anatomy; check karyotype	If absent uterus: distinguish MRKH (46,XX) from CAIS (46,XY); refer to gynecology and consider psychological support
Prolactin is mildly elevated	Repeat prolactin (ensure not stress-related); review medications	If persistent elevation >100 ng/mL, MRI likely to show prolactinoma; treat with dopamine agonist
Patient refuses treatment	Explore reasons; address fears and misconceptions	Respect autonomy (especially older adolescents); ensure understanding of consequences; offer follow-up
Family requests growth hormone for constitutional delay	Explain that GH does not significantly improve adult height in CDGP	GH is generally not indicated for isolated CDGP; focus on pubertal induction if desired
Bone age is significantly delayed — how much more will they grow?	Calculate predicted adult height using bone age-based methods (Bayley-Pinneau)	Reassure that significant growth potential remains; pubertal induction will not compromise final height if done appropriately

Treatment Approach by Diagnosis

Constitutional Delay of Growth and Puberty

Observation Only

Appropriate if patient and family not distressed
Reassure that puberty will occur spontaneously
Follow every 6-12 months to document progression
Final adult height typically normal

Short-Term Sex Steroid Therapy

Boys: Testosterone enanthate or cypionate 50-100 mg IM monthly for 3-6 months
Girls: Low-dose estrogen (conjugated estrogens 0.3 mg or ethinyl estradiol 5-10 mcg daily) for 3-6 months
Purpose: “Jumpstart” puberty; psychological benefit
Discontinue and observe for spontaneous progression

Permanent Hypogonadism (Hypogonadotropic or Hypergonadotropic)

Principles of Pubertal Induction

Goal: Mimic normal puberty — start low, go slow
Duration: Gradual dose increases over 2-3 years to reach adult replacement
Monitoring: Clinical response (Tanner staging), growth velocity, bone age, hormone levels
Boys: Testosterone (IM, topical gel, or subcutaneous pellets) — increase dose every 6 months
Girls: Start with estrogen alone; add progestin after 1-2 years or when breakthrough bleeding occurs
Fertility: For hypogonadotropic hypogonadism, gonadotropin therapy or pulsatile GnRH can induce fertility when desired

When to Refer

Refer To	Indication
Pediatric Endocrinology	All cases of confirmed delayed puberty; management of hormone replacement; complex cases
Genetics	Confirmed chromosomal abnormality (Turner, Klinefelter); suspected genetic syndrome; genetic counseling
Pediatric Gynecology	Primary amenorrhea with anatomical abnormality; vaginal agenesis; need for surgical intervention
Neurosurgery/Neuro-oncology	Pituitary or hypothalamic tumor identified on MRI
Pediatric Cardiology	Turner syndrome (cardiac screening); Noonan syndrome with cardiac involvement
Adolescent Medicine / Eating Disorders	Functional hypothalamic amenorrhea; suspected eating disorder; severe undernutrition
Psychology / Psychiatry	Significant psychological distress; body image issues; adjustment difficulties; gender dysphoria
Reproductive Endocrinology / Fertility	When fertility is desired; discussion of fertility preservation; gonadotropin therapy for spermatogenesis/ovulation

Troubleshooting: Puberty Not Progressing as Expected

Ask These Questions

Is the diagnosis correct? — Re-evaluate if expected constitutional delay is not progressing; consider permanent hypogonadism
Is the dose adequate? — Subtherapeutic dosing is common; check levels and adjust
Is the patient adherent? — Especially with injections; explore barriers to adherence
Is there an underlying condition affecting response? — Chronic disease, malabsorption, untreated hypothyroidism
Has bone age advanced too quickly? — If bone age advancing faster than height, may compromise final height
Is there a new problem? — Evolving pituitary deficiency; new diagnosis of hyperprolactinemia
Are there psychological barriers? — Ambivalence about growing up; gender identity concerns

8. Clinical Pearls and Pitfalls

Practical wisdom — key takeaways and common mistakes to avoid

Must-Know Clinical Pearls

Constitutional delay is a diagnosis of exclusion: While it accounts for the majority of cases (especially in boys), always evaluate for underlying pathology before reassuring the family.

Always test sense of smell: Anosmia is the key feature distinguishing Kallmann syndrome from isolated hypogonadotropic hypogonadism. Ask directly and perform formal testing — patients often don’t recognize they have reduced smell.

Testicular volume is the most reliable marker of puberty in boys: Use an orchidometer. Volume ≥4 mL indicates puberty has begun. Small, firm testes despite other pubertal signs suggest Klinefelter syndrome.

Pubic hair does not equal puberty: Adrenarche (pubic and axillary hair) is driven by adrenal androgens and is independent of gonadal function. Focus on breast development in girls and testicular volume in boys to assess HPG axis activation.

Breast development in primary amenorrhea changes the differential: If breasts are present, the patient has been exposed to estrogen — think anatomical causes (imperforate hymen, Müllerian agenesis) or androgen insensitivity, not just hypogonadism.

Get a karyotype in all hypergonadotropic hypogonadism: Turner syndrome (45,X) and Klinefelter syndrome (47,XXY) are common and have important management implications beyond hormone replacement.

The mini-puberty window is a diagnostic opportunity: In boys with micropenis or cryptorchidism, check LH, FSH, and testosterone in the first 3-6 months of life. Low levels during this window confirm hypogonadotropic hypogonadism years before delayed puberty would be apparent.

Celiac disease is a treatable cause — always screen: Celiac disease can present with isolated delayed puberty without classic GI symptoms. Tissue transglutaminase IgA is a simple screening test.

Short-term sex steroids can be both diagnostic and therapeutic: A 3-6 month trial helps distinguish constitutional delay (puberty continues after stopping) from permanent hypogonadism (puberty stalls), while providing psychosocial benefit.

Address the psychosocial impact early: Delayed puberty significantly affects self-esteem, body image, and peer relationships. Acknowledge these concerns and consider treatment for psychosocial benefit even if the underlying cause is benign.

Critical Pitfalls to Avoid

Assuming all delayed puberty is constitutional delay: While CDGP is common, assuming the diagnosis without appropriate workup misses important pathology. Every patient deserves at least a basic evaluation.

Forgetting to check smell: Anosmia is often unrecognized by patients and families. Failure to test misses Kallmann syndrome, which requires different counseling and management.

Missing Turner syndrome because the phenotype is subtle: Not all girls with Turner syndrome have classic features. Short stature with elevated FSH should prompt karyotype regardless of appearance.

Dismissing headaches as unrelated: Headaches in a patient with delayed puberty may indicate a pituitary or hypothalamic tumor. Always get an MRI if there are CNS symptoms.

Not recognizing arrested puberty as a red flag: Puberty that starts but stalls for more than 2 years is more concerning than complete absence of puberty and warrants thorough investigation.

Overlooking eating disorders in girls with functional amenorrhea: A low BMI with pubertal delay should trigger screening for restrictive eating and excessive exercise. These patients need nutritional and psychological intervention, not just hormone replacement.

Failing to check for other pituitary deficiencies: Isolated gonadotropin deficiency is common, but if MRI shows pituitary abnormality, always evaluate the entire pituitary axis (GH, TSH, ACTH, prolactin).

Delaying referral due to reassurance that “they’ll grow out of it”: While many will, delayed referral can cause psychological harm and may miss treatable conditions. When in doubt, refer early.

Forgetting cancer survivors need surveillance: Patients treated with chemotherapy or radiation need ongoing monitoring for gonadal failure, which may be immediate or develop over time.

Not discussing fertility early enough: Fertility implications should be discussed at diagnosis for conditions like Turner and Klinefelter syndromes. Options like oocyte or sperm cryopreservation should be considered before starting hormone therapy when possible.

Key Takeaways

Delayed puberty is defined as no testicular enlargement by age 14 in boys, or no breast development by age 13 in girls.
Constitutional delay is the most common cause (50-65% in boys, 25-30% in girls), but it is a diagnosis of exclusion.
Classify patients as hypogonadotropic (low LH/FSH — central problem) or hypergonadotropic (high LH/FSH — gonadal problem) to guide workup.
Bone age is typically delayed in constitutional delay and helps predict remaining growth potential.
Always test smell — anosmia indicates Kallmann syndrome.
Karyotype is essential in all cases of hypergonadotropic hypogonadism to identify Turner or Klinefelter syndrome.
MRI brain is indicated for all confirmed hypogonadotropic hypogonadism to exclude structural lesions.
Screen for celiac disease and chronic illness — these are treatable causes of functional pubertal delay.
The psychosocial impact is significant — address it proactively and consider treatment for this indication alone.
Short-term sex steroid therapy can serve dual diagnostic and therapeutic purposes in distinguishing CDGP from permanent hypogonadism.
For permanent hypogonadism, pubertal induction should mimic normal puberty — start low, go slow over 2-3 years.
Fertility counseling should be part of management for all forms of hypogonadism — options exist even for conditions previously considered infertile.

Quick Reference Algorithm

Systematic Approach to Delayed Puberty:

Confirm delayed puberty: No testicular enlargement (≥4 mL) by age 14 in boys; no breast development by age 13 in girls
Take a focused history: Use the “DELAYED” mnemonic — Development, Energy/nutrition, Lineage, Associated symptoms, Years of growth, Exposures, Distress
Perform a complete examination: Growth parameters, Tanner staging, syndrome-specific features, smell testing
Order baseline investigations: LH, FSH, testosterone/estradiol, bone age, CBC, CMP, TSH, celiac serology, prolactin
Classify by gonadotropin level:
- Low LH/FSH → Hypogonadotropic → MRI brain, full pituitary panel, smell test
- High LH/FSH → Hypergonadotropic → Karyotype, pelvic ultrasound (girls), cardiac/renal imaging if Turner
Make a diagnosis or working diagnosis: Constitutional delay is likely if family history positive, no red flags, delayed bone age, and healthy otherwise
Initiate management:
- Constitutional delay: Reassurance ± short-term sex steroids for psychosocial benefit
- Permanent hypogonadism: Pubertal induction with gradual hormone replacement
- Functional: Treat underlying condition (nutrition, chronic disease)
Follow up: Monitor pubertal progression, growth, bone age, and psychological well-being every 6-12 months
Plan for the future: Discuss fertility options, transition to adult care, long-term hormone replacement needs